GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human androgenic 17BETA-hydroxysteroid dehydrogenase type 5 in complexed with a potent inhibitor EM1404

Analyse Crystal structure of human androgenic 17BETA-hydroxysteroid dehydrogenase type… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1ZQ5
Type
protein
Length
314 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Aldo-keto reductase family 1 member C3
EC
1.1.1.62, 1.3.1.20, 1.1.1.188
UniProt
P42330
Ligands
E04, NAP
Pockets
3 · best druggability 0.81

Structure

x-ray diffraction · 1 distinct chain · 41% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAldo-keto reductase family 1 member C3 (EC 1.1.1.62, 1.3.1.20, 1.1.1.188)protein31441% helix, 16% strandP42330

Ligands and binding sites

  • E04 · 3-carboxamido-1,3,5(10)-estratrien-17(R)-spiro-2'(5',5'-dimethyl-6'oxo)tetrahydropyran · ligand · chains A
  • NAP · Nadp nicotinamide-adenine-dinucleotide phosphate · ligand · chains A
  • ACT · Acetate ion · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15690.810.8763ACT, E04, NAP
21070.410.7716empty
3570.280.7418empty

Compared structures

  • 1ZQ5 · Crystal structure of human androgenic 17beta-hydroxysteroid dehydrogenase type 5 in… · the same entry in another collection · chain A against A, TM-score 1.00
  • P42330 · AlphaFold monomer V2.0 prediction for aldo-keto reductase family 1 member C3 (P42330) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.